TheScientist.com - Magazine of the Life Sciences, Every Day, Online
  Please Login or Register
  • Home
  • Community
  • Current Issue
  • Browse Archive
  • Careers
  • Video & Multimedia
  • Subscribe

Front Cover
Advertisement
NRW: North Rhine-Westphalia
Supplements
  • Life Sciences in
    Ireland
  • Life Sciences in
    the Greater
    Phila. Region
  • Schizophrenia
  • Autoimmunity


Survey Series
  • Best Places to Work
  • $alary $urvey
  • The Scientist Video Awards
  • Lab Web Site and
    Video Awards

The Scientist Daily
  • Science headlines delivered daily.
    Register today.

Institutions
  • For Librarians
  • Recommend Us to Your Librarian

For Advertisers
  • Advertise with Us
  • Contact Ad Team
  • 2009 Media Kit



by SPIS MedWire

RESEARCH ROUND-UP

Sweet scent for CF sufferers
Bacterial infection in CF sufferers could be reduced by sugar inhalers.


News from The Scientist 2000, 1(1):20001010-01

Published 10 October 2000

A simple sugar used in inhalers could prevent the onset of bacterial infections in cystic fibrosis (CF) sufferers. Bacterial infections in CF sufferers occur because the level of salt concentration in the surface airway liquid is too high, preventing the production of an effective immune response to the invading bacteria. In a study published in the 10 October issue of PNAS, a team from the University of Iowa, USA, found that a sugar called xylitol could be used to lower the salt concentration in the airways. Xylitol is not used by airway bacteria, so it could enhance the ability of the immune system to kill bacteria without promoting bacterial growth. A nasal spray containing the sugar was tested on a dozen volunteers and it significantly reduced the number of nasal bacteria detected. Dr Michael Walsh commented: "The hope is that this could help prevent, or at least delay, the onset of infection in lungs of people with cystic fibrosis, and people who don't have cystic fibrosis but are prone to lung infections."


For FREE access to this article and more, you must register.

Not yet registered? Get free access
 

The article you are attempting to read is only available to registered users of The Scientist. Registration is FREE and only takes a few seconds.

 
 

Email

Password

> Forgot Password?
> FAQ
> Subscribe

 
Not yet registered? Get free access
 

Create your MyScientist account and access all of The Scientist's free content, tools and life science email newsletters, including:

 

> The current month’s print issue

> Daily & Bi-weekly e-mail newsletters

> Newsblogs with breaking headlines

> The Scientist Community

> Exclusive web extras

> The Scientist Careers

 

Premium content from The Scientist Archive, a comprehensive resource of over 22 years of past life science coverage, is available only by subscription. Subscribe today and get unlimited access

 

 





About TS | Contact | Advertise | Editorial Advisory Board | Privacy Policy
© 1986-2009 The Scientist